nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—Crohn's disease	0.376	1	CbGaD
Minocycline—ALOX5—Balsalazide—Crohn's disease	0.19	0.416	CbGbCtD
Minocycline—ALOX5—Mesalazine—Crohn's disease	0.152	0.333	CbGbCtD
Minocycline—ALOX5—Sulfasalazine—Crohn's disease	0.0849	0.186	CbGbCtD
Minocycline—SLC22A8—Mercaptopurine—Crohn's disease	0.0295	0.0646	CbGbCtD
Minocycline—CYCS—mouth—Crohn's disease	0.003	0.0575	CbGeAlD
Minocycline—CASP3—mouth—Crohn's disease	0.00257	0.0492	CbGeAlD
Minocycline—IL1B—mouth—Crohn's disease	0.00205	0.0393	CbGeAlD
Minocycline—CASP1—epithelium—Crohn's disease	0.00181	0.0347	CbGeAlD
Minocycline—CYCS—epithelium—Crohn's disease	0.00174	0.0334	CbGeAlD
Minocycline—CASP1—skin of body—Crohn's disease	0.00172	0.033	CbGeAlD
Minocycline—MMP9—mouth—Crohn's disease	0.00171	0.0328	CbGeAlD
Minocycline—CYCS—smooth muscle tissue—Crohn's disease	0.00168	0.0322	CbGeAlD
Minocycline—CYCS—skin of body—Crohn's disease	0.00166	0.0318	CbGeAlD
Minocycline—CASP1—mammalian vulva—Crohn's disease	0.00157	0.0301	CbGeAlD
Minocycline—CASP3—epithelium—Crohn's disease	0.00149	0.0286	CbGeAlD
Minocycline—CASP3—smooth muscle tissue—Crohn's disease	0.00144	0.0276	CbGeAlD
Minocycline—CASP3—skin of body—Crohn's disease	0.00142	0.0272	CbGeAlD
Minocycline—CASP1—lymphoid tissue—Crohn's disease	0.0014	0.0268	CbGeAlD
Minocycline—CASP1—digestive system—Crohn's disease	0.00138	0.0264	CbGeAlD
Minocycline—CYCS—lymphoid tissue—Crohn's disease	0.00134	0.0258	CbGeAlD
Minocycline—CYCS—digestive system—Crohn's disease	0.00133	0.0254	CbGeAlD
Minocycline—CASP3—mammalian vulva—Crohn's disease	0.0013	0.0248	CbGeAlD
Minocycline—IL1B—epithelium—Crohn's disease	0.00119	0.0229	CbGeAlD
Minocycline—CASP3—lymphoid tissue—Crohn's disease	0.00115	0.0221	CbGeAlD
Minocycline—IL1B—smooth muscle tissue—Crohn's disease	0.00115	0.0221	CbGeAlD
Minocycline—CASP3—digestive system—Crohn's disease	0.00114	0.0218	CbGeAlD
Minocycline—IL1B—skin of body—Crohn's disease	0.00114	0.0218	CbGeAlD
Minocycline—VEGFA—smooth muscle tissue—Crohn's disease	0.00113	0.0217	CbGeAlD
Minocycline—VEGFA—mammalian vulva—Crohn's disease	0.00102	0.0195	CbGeAlD
Minocycline—MMP9—epithelium—Crohn's disease	0.000995	0.0191	CbGeAlD
Minocycline—MMP9—smooth muscle tissue—Crohn's disease	0.000958	0.0184	CbGeAlD
Minocycline—MMP9—skin of body—Crohn's disease	0.000946	0.0181	CbGeAlD
Minocycline—IL1B—lymphoid tissue—Crohn's disease	0.000919	0.0176	CbGeAlD
Minocycline—IL1B—digestive system—Crohn's disease	0.000908	0.0174	CbGeAlD
Minocycline—CASP1—lymph node—Crohn's disease	0.000787	0.0151	CbGeAlD
Minocycline—MMP9—lymphoid tissue—Crohn's disease	0.000766	0.0147	CbGeAlD
Minocycline—CYCS—lymph node—Crohn's disease	0.000758	0.0145	CbGeAlD
Minocycline—ALOX5—smooth muscle tissue—Crohn's disease	0.000758	0.0145	CbGeAlD
Minocycline—MMP9—digestive system—Crohn's disease	0.000757	0.0145	CbGeAlD
Minocycline—SLC22A11—digestive system—Crohn's disease	0.000717	0.0138	CbGeAlD
Minocycline—SLC22A7—digestive system—Crohn's disease	0.0007	0.0134	CbGeAlD
Minocycline—IL1B—Methylprednisolone—Prednisone—Crohn's disease	0.000681	0.276	CbGdCrCtD
Minocycline—CASP3—lymph node—Crohn's disease	0.000649	0.0124	CbGeAlD
Minocycline—ALOX5—lymphoid tissue—Crohn's disease	0.000606	0.0116	CbGeAlD
Minocycline—ALOX5—digestive system—Crohn's disease	0.000598	0.0115	CbGeAlD
Minocycline—CYCS—Methyldopa—Mesalazine—Crohn's disease	0.000553	0.224	CbGdCrCtD
Minocycline—IL1B—lymph node—Crohn's disease	0.000519	0.00994	CbGeAlD
Minocycline—VEGFA—lymph node—Crohn's disease	0.00051	0.00978	CbGeAlD
Minocycline—MMP9—lymph node—Crohn's disease	0.000432	0.00829	CbGeAlD
Minocycline—IL1B—Fluorometholone—Prednisone—Crohn's disease	0.000422	0.171	CbGdCrCtD
Minocycline—Methacycline—ALB—Crohn's disease	0.000355	0.695	CrCbGaD
Minocycline—ALOX5—lymph node—Crohn's disease	0.000342	0.00655	CbGeAlD
Minocycline—IL1B—Budesonide—Prednisone—Crohn's disease	0.000282	0.114	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Prednisone—Crohn's disease	0.000172	0.0699	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Prednisone—Crohn's disease	0.000172	0.0699	CbGdCrCtD
Minocycline—Tetracycline—ALB—Crohn's disease	0.000156	0.305	CrCbGaD
Minocycline—VEGFA—Dexamethasone—Prednisone—Crohn's disease	9.2e-05	0.0373	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Prednisone—Crohn's disease	9.2e-05	0.0373	CbGdCrCtD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.47e-05	0.000399	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TNF—Crohn's disease	4.44e-05	0.000396	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—TYK2—Crohn's disease	4.44e-05	0.000396	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	4.4e-05	0.000393	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TNF—Crohn's disease	4.37e-05	0.00039	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.37e-05	0.00039	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.37e-05	0.00039	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL1B—Crohn's disease	4.37e-05	0.00039	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—IL6—Crohn's disease	4.36e-05	0.000389	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CXCL8—Crohn's disease	4.36e-05	0.000389	CbGpPWpGaD
Minocycline—IL1B—Immune System—CARD9—Crohn's disease	4.35e-05	0.000388	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—Crohn's disease	4.35e-05	0.000388	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—TYK2—Crohn's disease	4.34e-05	0.000387	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—STAT3—Crohn's disease	4.3e-05	0.000384	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—IL6—Crohn's disease	4.3e-05	0.000384	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—JAK2—Crohn's disease	4.23e-05	0.000377	CbGpPWpGaD
Minocycline—CASP1—Immune System—PTPN2—Crohn's disease	4.22e-05	0.000377	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—Crohn's disease	4.22e-05	0.000376	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL1B—Crohn's disease	4.18e-05	0.000373	CbGpPWpGaD
Minocycline—CASP1—Immune System—RBX1—Crohn's disease	4.17e-05	0.000372	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—JAK2—Crohn's disease	4.14e-05	0.000369	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TAGAP—Crohn's disease	4.1e-05	0.000366	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CXCL8—Crohn's disease	4.08e-05	0.000364	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.04e-05	0.00036	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—IL6—Crohn's disease	4.04e-05	0.00036	CbGpPWpGaD
Minocycline—CYCS—Metabolism—FADS1—Crohn's disease	4.03e-05	0.000359	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—ICAM1—Crohn's disease	4.02e-05	0.000359	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—IL6—Crohn's disease	3.96e-05	0.000354	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—Crohn's disease	3.95e-05	0.000353	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CRP—Crohn's disease	3.93e-05	0.00035	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GPX4—Crohn's disease	3.77e-05	0.000337	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—TLR4—Crohn's disease	3.76e-05	0.000336	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL6—Crohn's disease	3.75e-05	0.000335	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PLA2G4F—Crohn's disease	3.75e-05	0.000334	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	3.73e-05	0.000333	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL6—Crohn's disease	3.72e-05	0.000332	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—STAT3—Crohn's disease	3.66e-05	0.000327	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.66e-05	0.000327	CbGpPWpGaD
Minocycline—CASP1—Immune System—UBE2D1—Crohn's disease	3.66e-05	0.000326	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.65e-05	0.000325	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.65e-05	0.000325	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GCKR—Crohn's disease	3.64e-05	0.000325	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—Crohn's disease	3.63e-05	0.000324	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RSPO3—Crohn's disease	3.59e-05	0.00032	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	3.59e-05	0.00032	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.57e-05	0.000318	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—TYK2—Crohn's disease	3.55e-05	0.000317	CbGpPWpGaD
Minocycline—CASP1—Immune System—RIPK2—Crohn's disease	3.55e-05	0.000317	CbGpPWpGaD
Minocycline—CASP1—Immune System—ITGA4—Crohn's disease	3.55e-05	0.000317	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL6—Crohn's disease	3.53e-05	0.000314	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—Crohn's disease	3.51e-05	0.000313	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IL6—Crohn's disease	3.5e-05	0.000313	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—Crohn's disease	3.49e-05	0.000312	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	3.47e-05	0.000309	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL3—Crohn's disease	3.46e-05	0.000309	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL6—Crohn's disease	3.43e-05	0.000306	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL6—Crohn's disease	3.4e-05	0.000304	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SEL1L—Crohn's disease	3.4e-05	0.000303	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—JAK2—Crohn's disease	3.39e-05	0.000302	CbGpPWpGaD
Minocycline—CASP1—Immune System—RASGRP1—Crohn's disease	3.35e-05	0.000299	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD79A—Crohn's disease	3.34e-05	0.000298	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—Crohn's disease	3.29e-05	0.000294	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ACKR2—Crohn's disease	3.29e-05	0.000293	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—STAT3—Crohn's disease	3.28e-05	0.000293	CbGpPWpGaD
Minocycline—CASP1—Immune System—TAB1—Crohn's disease	3.28e-05	0.000292	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—TYK2—Crohn's disease	3.27e-05	0.000292	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.24e-05	0.000289	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—ICAM1—Crohn's disease	3.23e-05	0.000288	CbGpPWpGaD
Minocycline—CASP1—Immune System—NOD2—Crohn's disease	3.22e-05	0.000287	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL6—Crohn's disease	3.19e-05	0.000285	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTMR3—Crohn's disease	3.19e-05	0.000284	CbGpPWpGaD
Minocycline—IL1B—Immune System—NOD1—Crohn's disease	3.18e-05	0.000283	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—Crohn's disease	3.16e-05	0.000282	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—JAK2—Crohn's disease	3.12e-05	0.000278	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MLN—Crohn's disease	3.12e-05	0.000278	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR9—Crohn's disease	3.11e-05	0.000277	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.08e-05	0.000275	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IFNG—Crohn's disease	3.06e-05	0.000273	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—STAT3—Crohn's disease	3.04e-05	0.000271	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—Crohn's disease	3.03e-05	0.000271	CbGpPWpGaD
Minocycline—CASP1—Immune System—SOCS1—Crohn's disease	3.03e-05	0.00027	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.03e-05	0.00027	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—Crohn's disease	2.98e-05	0.000266	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.97e-05	0.000265	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—TYK2—Crohn's disease	2.93e-05	0.000262	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1B—Crohn's disease	2.9e-05	0.000259	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GPR65—Crohn's disease	2.89e-05	0.000258	CbGpPWpGaD
Minocycline—IL1B—Immune System—CCR6—Crohn's disease	2.88e-05	0.000257	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ACKR2—Crohn's disease	2.85e-05	0.000254	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TAGAP—Crohn's disease	2.85e-05	0.000254	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—Crohn's disease	2.82e-05	0.000252	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ITGA4—Crohn's disease	2.82e-05	0.000251	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	2.8e-05	0.00025	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—JAK2—Crohn's disease	2.8e-05	0.00025	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL3—Crohn's disease	2.75e-05	0.000245	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL18—Crohn's disease	2.73e-05	0.000244	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.72e-05	0.000243	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MLN—Crohn's disease	2.7e-05	0.000241	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—ALB—Crohn's disease	2.7e-05	0.000241	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—RASGRP1—Crohn's disease	2.66e-05	0.000237	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.65e-05	0.000237	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD4—Crohn's disease	2.65e-05	0.000237	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTPN2—Crohn's disease	2.64e-05	0.000235	CbGpPWpGaD
Minocycline—IL1B—Immune System—RBX1—Crohn's disease	2.61e-05	0.000233	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.57e-05	0.000229	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	2.57e-05	0.000229	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—Crohn's disease	2.56e-05	0.000228	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—Crohn's disease	2.55e-05	0.000228	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.53e-05	0.000225	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	2.51e-05	0.000224	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RSPO3—Crohn's disease	2.49e-05	0.000222	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—STAT3—Crohn's disease	2.49e-05	0.000222	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—FADS1—Crohn's disease	2.48e-05	0.000221	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—ALB—Crohn's disease	2.48e-05	0.000221	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TAGAP—Crohn's disease	2.47e-05	0.000221	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL6—Crohn's disease	2.45e-05	0.000218	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—SMAD3—Crohn's disease	2.44e-05	0.000218	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2RA—Crohn's disease	2.42e-05	0.000216	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SEL1L—Crohn's disease	2.36e-05	0.000211	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GPX4—Crohn's disease	2.33e-05	0.000207	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—Crohn's disease	2.3e-05	0.000205	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—Crohn's disease	2.29e-05	0.000205	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.29e-05	0.000205	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—STAT3—Crohn's disease	2.29e-05	0.000204	CbGpPWpGaD
Minocycline—IL1B—Immune System—UBE2D1—Crohn's disease	2.29e-05	0.000204	CbGpPWpGaD
Minocycline—CASP1—Immune System—CRP—Crohn's disease	2.29e-05	0.000204	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.27e-05	0.000203	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GCKR—Crohn's disease	2.25e-05	0.0002	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—TYK2—Crohn's disease	2.23e-05	0.000199	CbGpPWpGaD
Minocycline—IL1B—Immune System—RIPK2—Crohn's disease	2.22e-05	0.000198	CbGpPWpGaD
Minocycline—IL1B—Immune System—ITGA4—Crohn's disease	2.22e-05	0.000198	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR4—Crohn's disease	2.19e-05	0.000196	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—Crohn's disease	2.17e-05	0.000193	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL3—Crohn's disease	2.16e-05	0.000193	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RSPO3—Crohn's disease	2.16e-05	0.000193	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR9—Crohn's disease	2.16e-05	0.000193	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—JAK2—Crohn's disease	2.13e-05	0.00019	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—Crohn's disease	2.12e-05	0.000189	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—SMAD3—Crohn's disease	2.12e-05	0.000189	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.11e-05	0.000188	CbGpPWpGaD
Minocycline—CASP1—Immune System—ICAM1—Crohn's disease	2.1e-05	0.000187	CbGpPWpGaD
Minocycline—IL1B—Immune System—RASGRP1—Crohn's disease	2.09e-05	0.000187	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD79A—Crohn's disease	2.09e-05	0.000186	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR6—Crohn's disease	2.06e-05	0.000184	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SEL1L—Crohn's disease	2.05e-05	0.000183	CbGpPWpGaD
Minocycline—IL1B—Immune System—TAB1—Crohn's disease	2.05e-05	0.000183	CbGpPWpGaD
Minocycline—IL1B—Immune System—NOD2—Crohn's disease	2.01e-05	0.000179	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GPR65—Crohn's disease	2.01e-05	0.000179	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CXCL8—Crohn's disease	1.99e-05	0.000177	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—TYK2—Crohn's disease	1.94e-05	0.000173	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.93e-05	0.000172	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2RA—Crohn's disease	1.92e-05	0.000172	CbGpPWpGaD
Minocycline—IL1B—Immune System—SOCS1—Crohn's disease	1.9e-05	0.000169	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR9—Crohn's disease	1.87e-05	0.000167	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RBX1—Crohn's disease	1.86e-05	0.000166	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—JAK2—Crohn's disease	1.85e-05	0.000165	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTGER4—Crohn's disease	1.81e-05	0.000162	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.79e-05	0.00016	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GPR65—Crohn's disease	1.74e-05	0.000155	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—Crohn's disease	1.74e-05	0.000155	CbGpPWpGaD
Minocycline—CASP1—Immune System—TYK2—Crohn's disease	1.71e-05	0.000152	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL18—Crohn's disease	1.71e-05	0.000152	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.7e-05	0.000152	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—UBE2D1—Crohn's disease	1.63e-05	0.000146	CbGpPWpGaD
Minocycline—CASP1—Immune System—JAK2—Crohn's disease	1.63e-05	0.000145	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.61e-05	0.000143	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.6e-05	0.000143	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNG—Crohn's disease	1.6e-05	0.000143	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—Crohn's disease	1.6e-05	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—STAT3—Crohn's disease	1.6e-05	0.000142	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TYK2—Crohn's disease	1.59e-05	0.000142	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RIPK2—Crohn's disease	1.58e-05	0.000141	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL3—Crohn's disease	1.55e-05	0.000138	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD4—Crohn's disease	1.54e-05	0.000138	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—JAK2—Crohn's disease	1.52e-05	0.000135	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2RA—Crohn's disease	1.52e-05	0.000135	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RASGRP1—Crohn's disease	1.49e-05	0.000133	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—Crohn's disease	1.43e-05	0.000128	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR6—Crohn's disease	1.43e-05	0.000128	CbGpPWpGaD
Minocycline—IL1B—Immune System—CRP—Crohn's disease	1.43e-05	0.000127	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—Crohn's disease	1.43e-05	0.000127	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.4e-05	0.000125	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ALB—Crohn's disease	1.39e-05	0.000124	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TYK2—Crohn's disease	1.38e-05	0.000123	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR4—Crohn's disease	1.37e-05	0.000122	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SOCS1—Crohn's disease	1.35e-05	0.000121	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—JAK2—Crohn's disease	1.32e-05	0.000118	CbGpPWpGaD
Minocycline—IL1B—Immune System—ICAM1—Crohn's disease	1.31e-05	0.000117	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RBX1—Crohn's disease	1.29e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—JAK2—Crohn's disease	1.29e-05	0.000115	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	1.28e-05	0.000115	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTGER4—Crohn's disease	1.26e-05	0.000112	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR6—Crohn's disease	1.24e-05	0.000111	CbGpPWpGaD
Minocycline—CASP1—Immune System—STAT3—Crohn's disease	1.2e-05	0.000107	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SMAD3—Crohn's disease	1.17e-05	0.000104	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	1.17e-05	0.000104	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALB—Crohn's disease	1.16e-05	0.000103	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—UBE2D1—Crohn's disease	1.13e-05	0.000101	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RBX1—Crohn's disease	1.12e-05	0.0001	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—Crohn's disease	1.12e-05	9.95e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—STAT3—Crohn's disease	1.11e-05	9.94e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RIPK2—Crohn's disease	1.1e-05	9.81e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTGER4—Crohn's disease	1.09e-05	9.75e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—Crohn's disease	1.09e-05	9.73e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2RA—Crohn's disease	1.08e-05	9.65e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL3—Crohn's disease	1.07e-05	9.57e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—TYK2—Crohn's disease	1.07e-05	9.52e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RASGRP1—Crohn's disease	1.04e-05	9.25e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—JAK2—Crohn's disease	1.02e-05	9.08e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—Crohn's disease	1.01e-05	9.05e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNG—Crohn's disease	1e-05	8.92e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—UBE2D1—Crohn's disease	9.85e-06	8.78e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	9.8e-06	8.74e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—STAT3—Crohn's disease	9.68e-06	8.63e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—Crohn's disease	9.66e-06	8.61e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—Crohn's disease	9.65e-06	8.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RIPK2—Crohn's disease	9.55e-06	8.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—Crohn's disease	9.47e-06	8.45e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SOCS1—Crohn's disease	9.4e-06	8.38e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL3—Crohn's disease	9.31e-06	8.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RASGRP1—Crohn's disease	9.01e-06	8.03e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—Crohn's disease	8.38e-06	7.47e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—Crohn's disease	8.35e-06	7.45e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	8.18e-06	7.29e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SOCS1—Crohn's disease	8.16e-06	7.28e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMAD3—Crohn's disease	8.12e-06	7.24e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—Crohn's disease	7.79e-06	6.94e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TYK2—Crohn's disease	7.63e-06	6.8e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2RA—Crohn's disease	7.51e-06	6.7e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—STAT3—Crohn's disease	7.48e-06	6.67e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—JAK2—Crohn's disease	7.28e-06	6.49e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—Crohn's disease	7.15e-06	6.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMAD3—Crohn's disease	7.04e-06	6.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—Crohn's disease	6.76e-06	6.03e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL8—Crohn's disease	6.64e-06	5.92e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2RA—Crohn's disease	6.52e-06	5.82e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—Crohn's disease	6.25e-06	5.58e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—STAT3—Crohn's disease	5.34e-06	4.76e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TYK2—Crohn's disease	5.29e-06	4.72e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—Crohn's disease	5.22e-06	4.66e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—JAK2—Crohn's disease	5.05e-06	4.5e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL8—Crohn's disease	4.61e-06	4.11e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TYK2—Crohn's disease	4.6e-06	4.1e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—JAK2—Crohn's disease	4.38e-06	3.91e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL8—Crohn's disease	4e-06	3.57e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—Crohn's disease	3.73e-06	3.33e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STAT3—Crohn's disease	3.71e-06	3.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STAT3—Crohn's disease	3.22e-06	2.87e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—Crohn's disease	2.59e-06	2.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—Crohn's disease	2.25e-06	2e-05	CbGpPWpGaD
